A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Obese Adult Patients With Schizophrenia While Taking Antipsychotic Medications (GRATITUDE II)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
This Phase 2, double-blind, placebo-controlled, randomized study is to assess the safety, efficacy, and pharmacokinetics (PK) of miricorilant (CORT118335) in obese patients with schizophrenia treated with antipsychotic medications.
Epistemonikos ID: 85c58f9cce08b94f6f6c105ddacb8ac91ff04f42
First added on: May 07, 2024